A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection
Clinical trial NCT02066428 · COMPLETED
Trial details
- NCT number
- NCT02066428
- Sponsor
- Aeras
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2009-05-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.